IRIS
CUSI, MARIA GRAZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.959
EU - Europa 15.487
AS - Asia 8.362
SA - Sud America 1.522
AF - Africa 572
Continente sconosciuto - Info sul continente non disponibili 522
OC - Oceania 34
Totale 44.458
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.696
IT - Italia 3.023
RU - Federazione Russa 3.003
GB - Regno Unito 2.710
CN - Cina 2.708
SG - Singapore 2.539
IE - Irlanda 2.008
BR - Brasile 1.257
UA - Ucraina 978
SE - Svezia 957
VN - Vietnam 905
FR - Francia 864
DE - Germania 853
HK - Hong Kong 718
FI - Finlandia 498
KR - Corea 411
ZA - Sudafrica 299
IN - India 270
BD - Bangladesh 173
CA - Canada 141
TR - Turchia 113
ES - Italia 111
NL - Olanda 97
IQ - Iraq 92
PL - Polonia 89
AR - Argentina 79
NG - Nigeria 73
CI - Costa d'Avorio 65
PK - Pakistan 61
MX - Messico 59
BE - Belgio 55
JP - Giappone 55
AT - Austria 50
EC - Ecuador 49
ID - Indonesia 45
CZ - Repubblica Ceca 41
SA - Arabia Saudita 41
CO - Colombia 34
VE - Venezuela 31
KE - Kenya 27
UZ - Uzbekistan 26
MA - Marocco 25
CL - Cile 24
AU - Australia 23
PH - Filippine 20
EU - Europa 19
PE - Perù 19
AE - Emirati Arabi Uniti 16
AL - Albania 16
JO - Giordania 16
LT - Lituania 16
EG - Egitto 15
MY - Malesia 14
NP - Nepal 14
TN - Tunisia 14
DZ - Algeria 13
KZ - Kazakistan 13
IL - Israele 12
PT - Portogallo 12
PY - Paraguay 12
PA - Panama 11
RS - Serbia 11
UY - Uruguay 11
GR - Grecia 10
IM - Isola di Man 10
NZ - Nuova Zelanda 10
SC - Seychelles 10
TH - Thailandia 10
CH - Svizzera 9
ET - Etiopia 9
IR - Iran 9
JM - Giamaica 9
AZ - Azerbaigian 8
CR - Costa Rica 8
BG - Bulgaria 7
HN - Honduras 7
HU - Ungheria 7
LB - Libano 7
GE - Georgia 6
GH - Ghana 6
NO - Norvegia 6
PS - Palestinian Territory 6
SY - Repubblica araba siriana 6
TT - Trinidad e Tobago 6
AM - Armenia 5
BO - Bolivia 5
CY - Cipro 5
DO - Repubblica Dominicana 5
HR - Croazia 5
MT - Malta 5
OM - Oman 5
QA - Qatar 5
RO - Romania 5
DK - Danimarca 4
GT - Guatemala 4
KG - Kirghizistan 4
KW - Kuwait 4
LK - Sri Lanka 4
LU - Lussemburgo 4
LV - Lettonia 4
Totale 43.889
Salva come PNG Salva come JPEG
Città #
Southend 2.288
Dallas 1.999
Dublin 1.969
Fairfield 1.484
Singapore 1.470
Ashburn 1.433
Chandler 1.124
Moscow 856
Santa Clara 818
Jacksonville 771
Woodbridge 770
Milan 714
San Jose 694
Hong Kong 662
Beijing 660
Seattle 638
Wilmington 624
Houston 582
Cambridge 534
Hefei 508
Siena 507
Ann Arbor 498
Seoul 397
Princeton 338
Council Bluffs 316
Los Angeles 286
Rome 272
Ho Chi Minh City 268
Nanjing 268
Johannesburg 267
New York 262
Helsinki 242
Menlo Park 233
The Dalles 232
Lauterbourg 223
Hanoi 212
Munich 193
Boardman 132
Buffalo 122
São Paulo 122
San Mateo 115
Florence 109
Nanchang 97
San Diego 92
London 80
Orem 77
Fremont 75
Shanghai 72
Abuja 70
Frankfurt am Main 68
Redondo Beach 68
Dong Ket 67
Abidjan 65
Turku 62
Warsaw 61
Columbus 60
Dearborn 57
Bengaluru 56
Chicago 56
Málaga 56
Shenyang 54
Hebei 52
Brussels 50
Montreal 49
Tianjin 49
Izmir 47
Chennai 46
Tokyo 46
Toronto 46
Atlanta 45
Da Nang 45
Rio de Janeiro 42
Lappeenranta 41
San Francisco 39
Changsha 38
Guangzhou 38
Norwalk 38
Figino 36
Haiphong 36
Lancaster 35
Nuremberg 34
Turin 34
Düsseldorf 32
Jiaxing 32
Vienna 32
Washington 32
Kunming 31
Phoenix 30
Baghdad 29
Brooklyn 29
Stockholm 29
Venezia 29
Tashkent 26
Porto Alegre 25
Amsterdam 24
Belo Horizonte 24
Bologna 24
Jinan 24
Boston 23
Dhaka 23
Totale 28.889
Salva come PNG Salva come JPEG
Nome #
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 408
Diagnostic tools for Toscana virus infection 395
Immune response analysis to Measles virus in subjects vaccinated with MMR vaccine and naturally infected subjects. 394
A Respiratory Syncytial Virus Vaccine Vectored by a Stable Chimeric and Replication-Deficient Sendai Virus Protects Mice without Inducing Enhanced Disease 385
Valutazione di un test in chemiluminescenza per la diagnosi sierologica di Leishmaniosi Viscerale 377
Antipeptide monoclonal antibodies inhibit the binding of rabiesvirus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor 369
ANDAMENTO LONGITUDINALE DI BIOMARKERS DI INFIAMMAZIONE ED IMMUNOATTIVAZIONE IN PAZIENTI SOTTOPOSTI A TRAPIANTO DI RENE: UN RUOLO DELLA REPLICAZIONE DI CMV? 358
Anti-angiogenetic effects of immune-reconstituted influenza virosomes assembled with parathyroid hormone-related protein derived peptide vaccine. 356
ERITEMA NODOSO RECIDIVANTE E PERSISTENTE REPLICA DI EPSTEIN-BARR VIRUS 340
Plasmablastic transformation of a pre-existing plasmacytoma: a possible role for reactivation of Epstein Barr virus infection. 338
Phase Ib study of poly-epitope peptide vaccination to thymidylate synthase (TSPP) and GOLFIG chemo-immunotherapy for treatment of metastatic colorectal cancer patients 338
Non-granulomatous cerebellar infection by Acanthamoeba spp. in an immunocompetent host 330
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 329
Peripheral biomarkers' panel for severe COVID-19 patients 322
Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients. 308
Analisi retrospettiva su infezioni invasive e non invasive da batteri Gram negativi non fermentanti in pazienti ospedalizzati 307
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 306
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 292
HCMV infection in renal transplant recipients: a retrospective cohort study 290
Non-HCV-related cryoglobulinemic vasculitis and parvovirus-B19 infection 289
Immunization with Toscana virus N-Gc proteins protects mice against virus challenge 288
Antibody response to SARS-CoV-2 in infected patients with different clinical outcome 284
Analysis of genetic and viral determinants of HBsAg levels in patients with chronic HBV infection 280
Un rarissimo caso di infestazione parassitaria cerebellare da Acanthamoeba spp. In soggetto immunocompetente: primo caso in Italia. 278
PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach 277
Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients 274
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 272
Cetuximab +/- chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro 269
Seroprevalence of hepatitis E virus (HEV) infection in blood donors and renal transplant recipients: a retrospective study from central Italy [Sieroprevalenza dell’infezione da virus dell’epatite E (HEV) in donatori di sangue e pazienti trapiantati di rene: Uno studio retrospettivo dal centro Italia] 268
Beyond the biological effect of a chemically characterized poplar propolis: Antibacterial and antiviral activity and comparison with flurbiprofen in cytokines release by LPS-stimulated human mononuclear cells 268
5-fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine 266
Peptidi epitopici immunogenici del CEA da utilizzare nella chemio-immunoterapia del carcinoma del colon-retto e della mammella. 263
Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy 262
Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience 260
In vitro neuraminidase inhibitory effect and activity against influenza virus A H1N1 of herbal drugs used for common cold 258
Dendritic cell-cediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro 257
EBV Reactivation and Chromosomal Polysomies: Euphorbia tirucalli as a Possible Cofactor in Endemic Burkitt Lymphoma. 256
Whole-Genome Sequence of SARS-CoV-2 Isolate Siena-1/2020 253
Serial KL-6 measurements in COVID-19 patients 252
Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs. 250
Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis 248
FIBRILLO-FLUTTER IN ASSENZA DI SEGNI DI MIOCARDITE IN CORSO DI INFEZIONE DA EBV 242
Testicular involvement during Toscana-virus infection: an unusual manifestation? 242
Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane/tazobactam and comparators, and molecular epidemiology of carbapenemase producers 240
Proprietà di legame di anticorpi monoclonali contro il virus della rabbia ottenuti per mezzo di immunizzazione con un peptide sintetico 236
Efficient delivery of DNA to dendritic cells mediated by influenza virosomes 235
Anatomy of an extensively drug-resistant Klebsiella pneumoniae outbreak in Tuscany, Italy 235
Age related changes in T cell mediated immune response and effector memory to Respiratory Syncytial Virus (RSV) in healthy subjects 232
Seroprevalence to measles virus after vaccination or natural infection in an adult population, in Italy 230
Fast duplex one-step RT-PCR for rapid differential diagnosis of entero- or toscana virus meningitis 229
Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis 229
Antibody response to wild rubella virus structural proteins following immunization with RA 27/3 live attenuated vaccine 228
Comparison of a new prototype immunochromatographic assay and a commercial enzyme-linked immunosorbent assay for the detection of serum antibodies against Toscana virus 228
Overview of Anti-SARS-CoV-2 Immune Response Six Months after BNT162b2 mRNA Vaccine 227
Identification of a neutralizing epitope on tosv gn glycoprotein 222
Type I interferons induced by endogenous or exogenous viral infections promote metastasis and relapse of leishmaniasis 222
SARS-CoV-2 in pleural fluid in a kidney transplant patient 221
A Poly-epitopic peptide vaccine against the thymidylate synthase (TS). A synergistic therapeutic combination with fluoropyrimidine-based-chemotherapy 220
Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase lb program 219
Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial) 217
Coronavirus HKU 1 infection with bronchiolitis, pericardial effusion and acute respiratory failure in obese adult female 215
Incidence and risk factors for respiratory tract bacterial colonization and infection in lung transplant recipients 215
Detection of asymptomatic SARS-CoV-2 infections among healthcare workers: Results from a large-scale screening program based on rapid serological testing 215
Toscana virus induces interferon although its NSs protein reveals antagonistic activity. 213
Retrospective diagnosis of West Nile virus infection in a patient with meningoencephalitis in Tuscany, Italy 212
Immune-modulating effects of the newest cetuximab-based chemoimmunotherapy regimen in advanced colorectal cancer patients 212
A Polyepitope DNA Vaccine Targeted to Her-2/ErbB-2 Elicits a Broad Range of Human and Murine CTL Effectors to Protect against Tumor Challenge 210
Compartimentalizzazione di HCMV: mancata appropiatezza della sola DNAemia nella diagnosi e nella terapia di una polmonite da HCMV post-trapianto polmonare 209
Pathogenic mechanism of Helicobacter pylori: production of cytoxin 208
T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120 207
A Mediterranean arbovirus: the Toscana virus 207
Chemo-immunotherapy of colo-rectal cancer: Drug induced antigen specific cell-mediated immune response in vitro and in cancer patients 206
Virosoma dell'influenza immunoricostituito (IRIV) contenente il gene per CD40L come immunoprotettore tumorale CEA-specifico e usi immunogenici di esso. 206
Human Polymorphonuclear Cells Support Zika Virus to Cross Endothelial Monolayer and Access Bloodstream 205
Detection of RSV Genome in Cerebrospinal Fluid of a Patient with Guillain Barrè Syndrome: A Case Report 204
Seroprevalence of antibodies to Sandfly fever Sicilian virus in a sample population in Tuscany, Italy 204
Effetti della dieta sulla secrezione di calcitonina nel neonato [The effects of diet on the secretion of calcitonin in the newborn infant] 204
Synthetic peptides of rubella E1 glycoprotein for serological assays 203
Age-dependent seroprevalence of Toscana virus in central Italy and correlation with the clinical profile 202
Evaluation of a novel immunogenic vaccine platform based on a genome replication-deficient Sendai vector 201
Immune-reconstituted influenza virosome containing CD40L gene enhances the immunological and protective activity of a carcinoembryonic antigen anticancer vaccine 201
Infection prevention in endoscopy practice; comparative evaluation of reusable vs single use endoscopic valves 201
Applications of Influenza Virosomes as a delivery system 200
Omicron infection evokes cross-protection against SARS-CoV-2 variants in vaccinees 199
Seronegative Vaccinees May Not Benefit From Multiple Booster Doses of MMR Vaccine in Restoring Immunity 198
Urinary tract infections caused by Gram-negative bacteria in elderly hospitalized patients: epidemiology, clinical features and outcomes in the era of antimicrobial resistance 196
Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID 193
Efficient inactivation of sars-cov-2 and other rna or dna viruses with blue led light 193
Epidemiological and clinical study of viral respiratory tract infections in children from Italy 192
Development of a mouse model for the study of Toscana virus pathogenesis 192
ACKNOWLEDGEMENT OF REVIEWERS 192
Infections in liver and lung transplant recipients: A national prospective cohort 189
Immunological characterization of Respiratory Syncytial Virus N protein epitopes recognized by human cytotoxic T lymphocytes 187
Toscana Virus NSs protein inhibits the induction of type I interferon by interacting with RIG-I. 187
Comparative study of the immune response in mice immunized with four live attenuated strains of mumps virus by intranasal or intramuscular route. 186
SARS-CoV-2 Antibody Response in Persons with Past Natural Infection 186
Peripheral lymphocyte subset monitoring in COVID-19 Italian patients 185
Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein 182
Rapid identification of Toscana virus by nested PCR during an outbreak in the Siena area of Italy 182
Ubiquitin and not only unfolded domains drives toscana virus non-structural NSs protein degradation 181
Totale 24.748
Salva come PNG Salva come JPEG
Categoria #
all - tutte 138.381
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 138.381
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.424 0 272 145 200 127 88 121 141 218 279 249 584
2022/20234.058 248 324 509 539 412 817 80 349 424 102 166 88
2023/20243.124 109 108 267 178 101 817 1.073 76 18 77 64 236
2024/20256.357 181 354 556 342 713 354 306 376 554 280 647 1.694
2025/202615.136 1.156 2.111 1.574 1.787 2.714 621 1.651 541 582 811 421 1.167
2026/2027918 597 321 0 0 0 0 0 0 0 0 0 0
Totale 44.458